Adaptive Biotechnologies
Price & Volume
Stats
See more52W Range | $5.69-$20.76 |
Market Cap | $3.1B |
Shares Short | 10M |
Financials
See moreRevenue (12 Mos) | $252.7M |
Revenue Growth (YoY) | 102.4% |
Gross Profit (12 Mos) | $164.4M |
Diluted EPS | -$0.52 |
News
See moreYahoo Finance • 4 days ago
Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
Yahoo Finance • 6 days ago
Adaptive Biotechnologies (ADPT) Hits 3-Year High. Here’s Why
Yahoo Finance • 11 days ago
Continued Momentum Lifted Adaptive Biotechnologies Corporation (ADPT) in Q3
Yahoo Finance • last month
Adaptive Biotechnologies to Report Third Quarter 2025 Financial Results on November 5, 2025
About
CEO | Mr. Chad M. Robins M.B.A. |
CFO | Mr. Kyle Piskel |
Address | 1165 Eastlake Avenue East, Seattle, WA, United States, 98109 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 619 |
